The widespread availability of genome sequencing data has yielded different rare variant association methods in population-based or family-based designs. However, it is challenging to know which method is appropriate in practice. Our purpose of this paper is to provide a general review of the literature for rare variant association studies and suggestions on future research directions. This paper discusses methods for recent rare variant association studies in three categories. The first two categories are for population-based designs, with/without considering the direction of the effects of causal rare variants. In the third category, methods for family-based designs are concluded.
Introduction
Genome-wide association studies (GWAS) have successfully identified a large number of common variants underlying various complex diseases [1, 2] . However, current studies suggest that these common variants identified by GWAS only account for a small fraction of disease heritability [2, 3] . It is widely recognized that rare variants are considered to be responsible for the missing heritability [2] [3] [4] . Nextgeneration DNA sequencing technologies allow sequencing of parts of the genome for a large number of individuals and the whole genome for a set of individuals, and thus make directly testing rare variants feasible [3, [5] [6] [7] [8] [9] . Existing single-marker tests used to detect common variants on complex diseases may not be suitable for detecting rare variants due to the allelic heterogeneity and low frequency of rare variants [10] . Several methods using the strategy of collapsing a group of rare variants in a gene or a pathway have been proposed recently. These methods include the cohort allelic sums test (CAST) method [11] , the combined multivariate and collapsing (CMC) method [10] , the weighted sum (WS) method [12] , the variable minor allele frequency threshold (VT) method [13] , and the cumulative minorallele test (CMAT) method [14] , among others. All the above methods assume that all causal variants are risk to diseases, while some causal variants are protective to some diseases [15, 16] . More recently, several methods considering the direction of the effects of association have been proposed, including the C-alpha test [17] , the sequence kernel association test (SKAT) [18] , the adaptive sum (aSum) test [19] , and the step-up method [16] , etc. All aforementioned methods are only applicable to population-based designs with unrelated samples, whereas family-based designs have been shown to improve power to detect causal rare variants [4, 20] . In addition, population-based tests can be seriously confounded by population stratification in rare variant association studies while family-based tests are robust to population stratification. So far, only a few family-based rare variant association methods have been developed, including the sib-pair and odds ratio weighted sum statistics (SPWSS, ORWSS) [20] , two adaptive weighting methods (AW-FBAT, AW-Joint) [21] , the FBAT-based test (FBAT-T) [22] , the TOW for a family-based design (TOW-F) [23] , and the TOW for sib-pair designs (TOW-sib) [24] , among others. In this article, we will provide a general review of the literature for rare variant association studies. We summarize and discuss the methods for recent rare variant association studies in three categories. In the first two categories, we provide the summary on methods in population-based designs, with or without considering the direction of effects of causal rare variants. In the third category, methods in family-based designs are concluded.
Materials and Methods

Category 1: Methods not robust to the direction of effects of causal variants in population-based designs
Recently, the strategy of collapsing a group of rare variants, in a gene or a pathway, has been proposed. Morgenthaler and Thilly [11] developed the cohort allelic sums test (CAST) which collapses rare variants and then compares collapsed allele frequencies in cases and controls. CAST was a milestone of rare variant association studies and started a sequence of collapsing methods in later research. Li and Leal [10] extended the CAST to come up with the combined multivariate and collapsing (CMC) method in which rare variants are collapsed within different subgroups and the information of both collapsed rare variants and common variants is used in the association test. Both CAST and CMC need to choose a fixed minor allele frequency (MAF) threshold to define common and rare variants. Madsen and Browning [12] proposed the weighted sum (WS) method where both common and rare variants can be included, but the variants are weighted according to their allele frequencies. Thus, common variants are giving small weights while rare variants are given large weights. Price et al. [13] proposed the variable minor allele frequency threshold (VT) method which tests the association using the 'optimal' MAF threshold. Zawistowski et al. [14] developed the cumulative minorallele test (CMAT) which is based on the summation of minor allele counts across all sites for cases and controls. All these methods are burden tests and essentially test the effect of a weighted combination of variants in a genomic region. variance based on allele frequencies in the controls. These collapsing methods are more powerful than single-variant tests. However, they assume that all causal variants are risk to diseases, while causal variants may be protective to some diseases [15, 16] . When both risk and protective variants are present, the above mentioned methods are underpowered because the opposite association effects will counteract each other [26] .
Category 2: Methods robust to the direction of the effects of causal variants for population-based designs
More recently, several methods that are robust to the direction of the effects of causal variants have been proposed. Neale et al.
[17] developed a C-alpha test, comparing the expected variance to the actual variance of the distribution of rare variants in cases versus controls. Wu et al. [18] introduced the sequence kernel association test (SKAT), a variance-component score test, testing for association between variants in a region (both common and rare) while adjusting for covariates. Both C-alpha test and SKAT are essentially testing the variance of the effects rather than the mean. Han and Pan [19] proposed the dataadaptive Sum (aSum) test, which incorporates the signs of the observed [27] proposed two grouping strategies (GS) based on WS and used data to decide the direction of the effects of causal variant. Also based on WS, Ionita-Laza et al. [28] proposed the replication-based (R) method, where two one-sided replication-based statistics are applied to risk variants and protective variants, respectively. Sha et al. [29] proposed an adaptive clustering method and adaptive weighting method (AC/ AW) to detect rare variant association in the presence of neutral and/or protective variants. Both AC/AW methods are applicable to quantitative and qualitative traits, and have clear advantages from power to computational efficiency comparing with existing collapsing methods and data-driven methods that allow neutral and protective variants. The above methods in Category 2 are also essentially testing the effect of a weighted combination of variants. Thus, how to choose appropriate weights is critical to the performance of these methods. Lin and Tang [30] derived theoretically optimal procedures for combining rare mutations and applied a general score-based test (GS) to population-based samples based on regression models. [38] conducted longitudinal data analysis based on TOW and proposed L-TOW to detect rare variant association in population-based designs, since incorporating traits at multiple-time points may increase the statistical power by providing more information than only using the trait at a single-time point.
Category 3: Methods for family-based designs
For any type of study design, the statistical power will be improved when rare variants are enriched in samples. If one parent carries a copy of a rare allele, half of the offspring are expected to carry it, thus, variants that are rare in the general population could be common in certain families [39] . Therefore, family-based methods may improve power to detect causal rare variants [20, 40] . Moreover, for rare variant associations, population-based association tests can be seriously confounded by population stratification while family-based association tests are robust to population stratification. However, there are only a few methods for family-based designs available so far. (HB) method to identify casual rare haplotypes for qualitative traits. First, a set of risk haplotypes is detected using a small proportion of the sample. Then association with that set of identified haplotypes is tested in a larger case-control sample. Feng et al. [20] introduced a sib-pair weighted sum statistic (SPWSS) to detect both rare and common causal variants in a gene or a genomic region. SPWSS uses either affected or discordant sib-pairs in sequencing or genome-wide association data, is not affected by the directionality of the effect of causal variants, and does not require choosing a MAF threshold. Zhu and Xiong [40] transformed a population-based test to the familybased test by calculating the covariance matrix of the functional principal-component scores, and developed the family-based functional principal-component analysis (FPCA) for qualitative traits. De et al. [22] proposed a method (FBAT-T) in a family-based design by extending the traditional single-SNP Family-Based Association Test (FBAT). Sha et al. [26] proposed a test for Testing the Optimally Weighted combination of variants based on data of Parents and Affected Children (TOW-PAC). TOW-PAC tests the combined effect of rare and common variants in a genomic region by using optimal data-driven weights. Later, He et al. [41] incorporated rarevariant association analysis into the transmission disequilibrium test (TDT) framework [42] to analyze trio sequence data and proposed Rare Variant Extensions of the Transmission Disequilibrium Test (RV-TDT). Choi et al. [43] proposed a FAmily-based Rare Variant Association Test (FARVAT) for extended families. It is based on the quasi-likelihood of whole families. Epstein et al. [44] proposed a framework for rare variants in affected sib-ships (SIB) based on the logic that rare susceptibility variants should be found more often on regions shared identical by descent by affected siblings. They derived both burden and variance-component tests under the SIB framework. SIB does not require variant information from unaffected relatives. Sha and Zhang [24] tested association of an optimally weighted combination of variants for affected sib-pairs (TOW-sib), based on either unrelated individuals or affected sib-pairs.
Quantitative traits: Lin and Tang [30] used generalized linear mixed models to capture the dependence of trait and a score test statistic in a family-based design (GS-F). GS-F is applicable to both quantitative and qualitative traits and allows for covariates. Liu and Leal [45] proposed a unified framework of modeling extreme trait genetic associations (MEGA) for direct quantitative trait loci (QTL) mapping. The framework is based on the mixed effect model, which generalizes the Fisher's biometrical model [46] , coupled with a likelihood method. The QTL effects are modeled as fixed effect to facilitate joint analysis of multiple rare variants. Using MEGA and appropriate permutation algorithms, many rare variant tests for unrelated individuals can be extended to the tests for family data. Fang et al. [21] proposed two adaptive weighting methods, Adaptive Weighting Family-Based Association Test (AW-FBAT) and Adaptive Weighting Joint Test (AW-Joint). AW-FBAT uses between-family information to calculate adaptive weights and uses within-family information to test for association, while AW-Joint uses joint information of between-family and within-family components to calculate the adaptive weights and to test for association. Fang et al. [23] extended TOW for unrelated individuals to TOW-F, TOW for Family-based data. TOW-F is robust to population stratifications in a wide range of population structures. Feng et al. [47] provided meta-analysis of rare variants in families (META-F) which applied to both single-variant and gene-level association tests.
Discussion and Future Directions
As we can see in the previous section, many statistical methods in population-based designs for testing associations of rare variants have been developed. The summary of the currently popular methods is shown in Table 1 . Based on the objective and prior biological knowledge of a project in practice, researchers could narrow their choices and select appropriate methods. For rare variant associations, population-based association tests can be seriously confounded by population stratification, since the spectrum of rare variation can be very different in diverse populations. Current studies show that family- based association tests can be robust to population stratification. In family-based data, association information can be partitioned into between-family and within-family information [21] . Within-family information is robust to population stratification while betweenfamily information can be confounded by population stratification. In addition, from the statistical power point of view, the power under any type of study design can be improved when rare variants are enriched in the samples [20, 40] . Several popular statistical methods in family-based designs are summarized in Table 2 for researchers to compare. With the rapid advance of biotechnology, new biological knowledge will become available, and next-generation DNA sequencing technologies will allow sequencing the whole genome. It is significantly important to incorporate this new information to improve statistical power to detect rare variants associated with complex diseases. Continued development of novel statistical methods for identifying rare disease susceptibility variants is needed for population-based designs, and especially for family-based designs. We hope this paper can help researchers with practical problems on rare variants. Most of the methods summarized in this paper considered a single trait. However, a gene often affects multiple traits. Thus, analysis of multiple traits simultaneously will increase power to detect rare variant association. When the same variants affect multiple traits, trait values for an individual will tend to be correlated. Very few methods for common variants association studies have been proposed [48, 49] . However, this field is still under way and challenging, and needs our special attention. Meta-analysis has facilitated many discoveries in common variant association studies. It is essential for detecting associations with rare variants too, because meta-analysis can increase the sample size, especially for rare variant association studies. To better explore the relationship between rare variants and complex diseases, it is urgent and essential to develop efficient multiple-trait methods as well as meta-analysis for rare variants studies. 
